AXL antibodies

Details for Australian Patent Application No. 2008323206 (hide)

Owner U3 Pharma GmbH

Inventors Selle, Kerstin; Zwick-Wallasch, Esther; Wirtz, Peter; Hettmann, Thore; Ruhe, Jens; Niewohner, Jens; Rothe, Mike

Agent Davies Collison Cave

Pub. Number AU-A-2008323206

PCT Pub. Number WO2009/062690

Priority 07021931.6 12.11.07 EP

Filing date 12 November 2008

Wipo publication date 22 May 2009

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 31/282 (2006.01)

A61K 31/704 (2006.01)

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

Event Publications

10 June 2010 PCT application entered the National Phase

  PCT publication WO2009/062690 Priority application(s): WO2009/062690

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008323227-Branched polymers in medical devices

2008323199-C-19 steroids for therapeutic uses